appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
LowUndervalued compared to the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Chemo Pharma Laboratories standalone net profit rises 10.00% in the September 2021 quarter
1 year ago•Business Standard
Chemo Pharma Laboratories standalone net profit declines 62.50% in the June 2021 quarter
2 years ago•Business Standard
Chemo Pharma Laboratories reports standalone net profit of Rs 0.02 crore in the March 2021 quarter
2 years ago•Business Standard
Chemo Pharma Laboratories standalone net profit declines 42.86% in the December 2020 quarter
2 years ago•Business Standard
BRIEF-Chemo Pharma Laboratories To Consider & Appoint Bhavin Sheth As CEO - Investing.com India
2 years ago•Investing.com